Evoke plc (LON:EVOK – Get Free Report)’s stock price was down 10% during mid-day trading on Friday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares were traded during trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Wall Street Analysts Forecast Growth
Several research analysts have recently commented on the company. Berenberg Bank decreased their price objective on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a report on Wednesday, December 4th. Jefferies Financial Group restated a “buy” rating and set a GBX 140 ($1.81) price target on shares of Evoke in a research report on Monday, December 16th.
Get Our Latest Stock Analysis on EVOK
Evoke Trading Down 1.1 %
Evoke (LON:EVOK – Get Free Report) last released its quarterly earnings data on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share (EPS) for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. On average, analysts expect that Evoke plc will post 12.7648305 EPS for the current fiscal year.
Insider Buying and Selling at Evoke
In related news, insider Andrea Gisle Joosen acquired 14,572 shares of the firm’s stock in a transaction on Tuesday, January 28th. The stock was acquired at an average cost of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,202.69). 27.00% of the stock is currently owned by corporate insiders.
About Evoke
Featured Articles
- Five stocks we like better than Evoke
- How to Effectively Use the MarketBeat Ratings Screener
- MarketBeat Week in Review – 03/24 – 03/28
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- What to Know About Investing in Penny Stocks
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.